Loading companies
Loading company profiles, tickers, sectors, and latest research coverage.
Loading company profiles, tickers, sectors, and latest research coverage.
Find company pages that collect related theses, catalysts, risks, filings, and discussion in one place.
Browse curated company pages by ticker, exchange, or research theme.
Xenon Pharmaceuticals: epilepsy pipeline optionality with the cash clock in view
Open company ->Xometry: manufacturing marketplace scale with profitability still on trial
Open company ->XPeng: EV volume growth has to become durable margin and cash-flow proof
Open company ->XPO: less-than-truckload execution has to turn freight scale into cleaner cash flow
Open company ->DENTSPLY SIRONA: dental demand is not enough without cleaner cash conversion
Open company ->Xerox: the print cash-flow story is now a balance-sheet test
Open company ->Yalla Group: profitable Middle East social apps with platform durability still to prove
Open company ->Yext: AI search relevance needs to become software profit
Open company ->Full Truck Alliance: digital freight scale has to keep proving profitable network effects
Open company ->York Water: a small utility where rate base discipline matters more than size
Open company ->YPF: Argentina energy upside still has to clear leverage, capex and policy risk
Open company ->Yiren Digital: China fintech earnings with credit-cycle opacity at the center
Open company ->Zimmer Biomet: medtech durability still has to prove procedure demand, margin quality and cash conversion
Open company ->Zillow Group: housing traffic has to become profitable transaction and software proof
Open company ->ZIM: the shipping cash yield still depends on freight cycles
Open company ->Zions: regional bank earnings are solid, but deposit and credit risk set the terms
Open company ->ZTO Express: China parcel scale with ADR and margin risk attached
Open company ->AIIO: the EV revenue collapsed before the AI robot story arrived
Open company ->AMD: the AI-chip challenger has to turn demand into durable margins
Open company ->Amgen: the post-Horizon biotech has to turn scale into deleveraging and pipeline proof
Open company ->Amazon: AWS and ads have to fund the next wave of AI and logistics spending
Open company ->American Express: the premium-card engine has to keep credit risk from eating spend growth
Open company ->BA: Boeing's recovery is real only if cash flow follows the backlog
Open company ->BAC: the deposit machine is strong, but rates and credit still write the script
Open company ->